Ionis Pharmaceuticals (IONS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -92,528 | -381,387 | -151,993 | -23,387 | -146,938 |
| Depreciation Amortization | 3,606 | 5,867 | 2,230 | 1,161 | -69 |
| Accounts receivable | -7,625 | 26,129 | 67,580 | 39,608 | 52,481 |
| Accounts payable and accrued liabilities | -3,095 | -15,360 | -29,116 | -20,309 | -25,968 |
| Other Working Capital | -730,124 | -51,215 | -75,071 | -69,658 | -41,175 |
| Other Operating Activity | 36,947 | 147,383 | 55,496 | 73,148 | 10,894 |
| Operating Cash Flow | $-792,819 | $-268,583 | $-130,874 | $563 | $-150,775 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 560,069 | -220,692 | 176,156 | 77,888 | 183,687 |
| PPE Investments | -21,763 | -51,444 | -30,152 | -24,882 | -12,577 |
| Purchase Sale Intangibles | -1,486 | -5,640 | -4,275 | -2,615 | -651 |
| Other Investing Activity | -1,486 | -5,640 | -4,275 | -2,615 | -651 |
| Investing Cash Flow | $536,820 | $-277,776 | $141,729 | $50,391 | $170,459 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 770,000 | N/A | -82 | N/A |
| Debt Repayment | -44 | -286,764 | -123 | N/A | -42 |
| Common Stock Issued | 57,302 | 192,604 | 84,787 | 3,528 | 2,241 |
| Financing Cash Flow | $57,258 | $675,840 | $84,664 | $3,446 | $2,199 |
| Exchange Rate Effect | -138 | 702 | 745 | 827 | 232 |
| Beginning Cash Position | 372,260 | 242,077 | 242,077 | 242,077 | 242,077 |
| End Cash Position | 173,381 | 372,260 | 338,341 | 297,304 | 264,192 |
| Net Cash Flow | $-198,879 | $130,183 | $96,264 | $55,227 | $22,115 |
| Free Cash Flow | |||||
| Operating Cash Flow | -792,819 | -268,583 | -130,874 | 563 | -150,775 |
| Capital Expenditure | -21,763 | -51,444 | -30,152 | -24,882 | -12,577 |
| Free Cash Flow | -814,582 | -320,027 | -161,026 | -24,319 | -163,352 |